HK1174895A1 - Arachidonic acid analogs and methods for analgesic treatment using same - Google Patents

Arachidonic acid analogs and methods for analgesic treatment using same

Info

Publication number
HK1174895A1
HK1174895A1 HK13102048.3A HK13102048A HK1174895A1 HK 1174895 A1 HK1174895 A1 HK 1174895A1 HK 13102048 A HK13102048 A HK 13102048A HK 1174895 A1 HK1174895 A1 HK 1174895A1
Authority
HK
Hong Kong
Prior art keywords
methods
same
arachidonic acid
acid analogs
analgesic treatment
Prior art date
Application number
HK13102048.3A
Other languages
English (en)
Chinese (zh)
Inventor
.布羅斯特倫
.福爾克
Original Assignee
賽托麥蒂克斯有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 賽托麥蒂克斯有限公司 filed Critical 賽托麥蒂克斯有限公司
Publication of HK1174895A1 publication Critical patent/HK1174895A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/09Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an acyclic unsaturated carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/164Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/20Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/04Systems containing only non-condensed rings with a four-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicinal Preparation (AREA)
HK13102048.3A 2009-11-25 2013-02-18 Arachidonic acid analogs and methods for analgesic treatment using same HK1174895A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26443409P 2009-11-25 2009-11-25
PCT/US2010/058041 WO2011066414A1 (en) 2009-11-25 2010-11-24 Arachidonic acid analogs and methods for analgesic treatment using same

Publications (1)

Publication Number Publication Date
HK1174895A1 true HK1174895A1 (en) 2013-06-21

Family

ID=43478049

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13102048.3A HK1174895A1 (en) 2009-11-25 2013-02-18 Arachidonic acid analogs and methods for analgesic treatment using same

Country Status (12)

Country Link
US (2) US8658632B2 (xx)
EP (1) EP2504311B1 (xx)
JP (1) JP5796909B2 (xx)
KR (1) KR101865194B1 (xx)
CN (1) CN102725261B (xx)
BR (1) BR112012012391A2 (xx)
CA (1) CA2781436C (xx)
DK (1) DK2504311T3 (xx)
ES (1) ES2549924T3 (xx)
HK (1) HK1174895A1 (xx)
MX (1) MX2012005689A (xx)
WO (1) WO2011066414A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2208720A1 (en) * 2009-01-13 2010-07-21 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Novel eicosanoid derivatives
EP3388081A1 (en) * 2010-05-26 2018-10-17 Selecta Biosciences, Inc. Multivalent synthetic nanocarrier vaccines
CN103588663A (zh) * 2013-10-26 2014-02-19 史克勇 癌痛药
CN103588666A (zh) * 2013-10-26 2014-02-19 史克勇 一种呈高光学纯度的化合物
CN103588672A (zh) * 2013-10-28 2014-02-19 史克勇 一种治疗癌性疼痛的药物
CN103588667A (zh) * 2013-10-28 2014-02-19 史克勇 一种新化合物
KR102392893B1 (ko) 2014-01-22 2022-04-29 막스-델부뤽-센트럼 퓌어 몰레쿨라레 메디친 인 데어 헬름홀츠-게마인샤프트 신규한 cyp-아이코사노이드 유도체
WO2016179137A1 (en) * 2015-05-04 2016-11-10 Cytometix, Inc. Compositions and methods for delivery of polyunsaturated fatty acid derivatives and analogs
WO2020159576A1 (en) 2019-01-28 2020-08-06 Mitochondria Emotion, Inc. Mitofusin activators and methods of use thereof
US20220387357A1 (en) * 2021-06-04 2022-12-08 Cytometix, Inc. Method of Dosing a Pain Therapeutic
US11951083B2 (en) 2022-06-08 2024-04-09 Cytometix, Inc. Methods of manufacturing 14,15-epoxyeicosatrienoic acid analogs and improved therapeutic delivery of same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US160452A (en) 1875-03-02 Improvement in caps
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4777049A (en) 1983-12-01 1988-10-11 Alza Corporation Constant release system with pulsed release
US4663308A (en) 1984-07-18 1987-05-05 Medical College Of Ohio Method of use of polymers containing cross-linked azo bonds for releasing therapeutic agents into the lower gastrointestinal tract
JPH075484B2 (ja) * 1985-03-06 1995-01-25 帝人株式会社 血液脳関門通過性医薬品組成物
IL103932A (en) 1992-11-30 1997-02-18 Yissum Res & Dev Fatty acid and pharmaceutical compositions containing them
GB2323594A (en) * 1997-03-25 1998-09-30 Victor Martin 2-amino-alkanoic acid derivatives, 2-amino alcohols and diamines
AU1833600A (en) * 1998-11-24 2000-06-19 Andreas Goutopoulos Cannabimimetic lipid amides as useful medications
MX2007000615A (es) * 2004-07-16 2007-03-07 Janssen Pharmaceutica Nv Compuestos dimericos de piperidina, piperazina o morfolina o sus analogos de 7 miembros adecuados para el tratamiento de trastornos neurodegenerativos.
AU2005295878A1 (en) 2004-10-13 2006-04-27 University Of Connecticut Cannabinergic lipid ligands
EP2208720A1 (en) * 2009-01-13 2010-07-21 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Novel eicosanoid derivatives

Also Published As

Publication number Publication date
CA2781436A1 (en) 2011-06-03
US9096494B2 (en) 2015-08-04
EP2504311B1 (en) 2015-08-12
CN102725261B (zh) 2014-07-30
JP2013512255A (ja) 2013-04-11
CA2781436C (en) 2018-01-02
BR112012012391A2 (pt) 2020-10-20
US20140135401A1 (en) 2014-05-15
JP5796909B2 (ja) 2015-10-21
WO2011066414A1 (en) 2011-06-03
US8658632B2 (en) 2014-02-25
CN102725261A (zh) 2012-10-10
DK2504311T3 (en) 2015-11-16
KR101865194B1 (ko) 2018-06-08
KR20120101473A (ko) 2012-09-13
ES2549924T3 (es) 2015-11-03
MX2012005689A (es) 2012-08-31
EP2504311A1 (en) 2012-10-03
US20130023510A1 (en) 2013-01-24

Similar Documents

Publication Publication Date Title
HK1174895A1 (en) Arachidonic acid analogs and methods for analgesic treatment using same
EP2512236A4 (en) IMPROVED METHOD FOR THE ADMINISTRATION OF BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB)
HUS1600057I1 (hu) Kezelési eljárások ammónia-megkötõ hatóanyag alkalmazásával
HK1169804A1 (zh) 治療疼痛的方法
IL226352A0 (en) שקיטה@לטיפול@עם@מעקב@braf
IL214919A0 (en) Method for therapeutic use
EP2593109A4 (en) METHOD AND FORMULATIONS FOR THE TREATMENT OF SIALIC ACID DEFICIENCIES
EP2401976A4 (en) TREATMENT PROCESS FOR AN ENDOSCOPE
GB201018147D0 (en) Method of treatment
ZA201303813B (en) Methods of treatment using lipid compounds
EP2640825A4 (en) APPARATUS FOR AUTOMATIC NUCLEIC ACID CLEANING AND METHOD FOR AEROSOL PROTECTION
HRP20181877T1 (hr) Postupci za liječenje lijekovima koji uklanjaju amonijak
GB201003920D0 (en) Method of treatment
EP2598998A4 (en) DEVICE AND METHOD FOR MINIMIZING PROCESS LIST
EP2552915A4 (en) COMPOUNDS AND METHODS FOR THE TREATMENT OF HIV
EP2556471A4 (en) METHOD AND DEVICE FOR CARRYING OUT CLINICAL TRIALS
EP2638038A4 (en) METHOD OF TREATING MENTAL DISORDERS
GB201020045D0 (en) Method for the treatment of biogas
EP2585103A4 (en) METHOD OF TREATMENT
GB201018149D0 (en) Method of treatment
EP2532254A4 (en) METHOD FOR PROCESSING A LACTO-N BIOSE-CONTAINED SOLUTION
ZA201303359B (en) Method of treatment with braf inhibitor
SI2330892T1 (sl) Postopki zdravljenja z uporabo zdravil, ki odstranjujejo amoniak
GB201019936D0 (en) Therapeutic method
GB201005071D0 (en) Method of treatment